Evidence map›Paper›PMID 31906001›Full record

ReviewMarine drugs2019

Halophiles and Their Biomolecules: Recent Advances and Future Applications in Biomedicine.

Paulina Corral, Mohammad A Amoozegar, Antonio Ventosa

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 180 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Biotechnological Applications of Archaea.Progress in molecular and subcellular biology · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Paulina CorralDepartment of Biology, University of Naples Federico II, 80126 Naples, Italy.ORCID 0000-0002-7798-4816
Mohammad A AmoozegarDepartment of Microbiology, School of Biology, College of Science, University of Tehran, Tehran 14155-6955, Iran.ORCID 0000-0002-9638-0532
Antonio VentosaDepartment of Microbiology and Parasitology, Faculty of Pharmacy, University of Sevilla, 41012 Sevilla, Spain.ORCID 0000-0002-7573-0556
Universidad de Sevilla · ESUniversity of Naples Federico II · ITUniversity of Tehran · IR

Funding

Iranian National Science Foundation (INSF) MAAItalian Foundation with the South 2018-PDR-00533Junta de Andalucía BIO-213Spanish Ministry of Economy and Competitiveness (MINECO) CGL2017-83385-P
6 · The paper itself

Abstract

The organisms thriving under extreme conditions better than any other organism living on Earth, fascinate by their hostile growing parameters, physiological features, and their production of valuable bioactive metabolites. This is the case of microorganisms (bacteria, archaea, and fungi) that grow optimally at high salinities and are able to produce biomolecules of pharmaceutical interest for therapeutic applications. As along as the microbiota is being approached by massive sequencing, novel insights are revealing the environmental conditions on which the compounds are produced in the microbial community without more stress than sharing the same substratum with their peers, the salt. In this review are reported the molecules described and produced by halophilic microorganisms with a spectrum of action in vitro: antimicrobial and anticancer. The action mechanisms of these molecules, the urgent need to introduce alternative lead compounds and the current aspects on the exploitation and its limitations are discussed.

Indexed as

Anti-Infective AgentsAntineoplastic AgentsArchaeaBacteriaFungiHalobacterialesSalinityAnti-Infective AgentsAntineoplastic Agentsanticancer compoundsantimicrobial compoundsarchaea and fungibiomedicinebiomoleculeshalophilic bacteria

Identifiers

PMID31906001
PMCPMC7024382
OpenAlexW2996966685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.